FDA Inspection 980719 — Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd.
The FDA completed an inspection of Zhejiang Hisoar Chuannan Pharmaceutical Co. Ltd. on July 8, 2016 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 8, 2016
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Taizhou (China)